MDA
BMY icon

Minot DeBlois Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Minot DeBlois Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46 Hold
1
– – ﹤0.01% 230
2026
Q1 		$48 Hold
1
– – ﹤0.01% 220
2025
Q4 		$42 Hold
1
– – ﹤0.01% 219
2025
Q3 		$35 Sell
1
-297
-100% -$13.9K ﹤0.01% 243
2025
Q2 		$13.8K Hold
298
– – 0.01% 145
2025
Q1 		$18.2K Hold
298
– – 0.02% 136
2024
Q4 		$16.8K Buy
+298
New +$16.6K 0.02% 175

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Minot DeBlois Advisors's BMY Position: Q2 2026 in Review

Minot DeBlois Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 1 share worth $46. The position accounts for ﹤0.01% of the portfolio, ranked #230.

Minot DeBlois Advisors first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $18.2K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Minot DeBlois Advisors held 1 share of Bristol-Myers Squibb worth $46 as of Q2 2026.
  • Minot DeBlois Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Minot DeBlois Advisors's portfolio in Q2 2026, its #230 holding.
  • Minot DeBlois Advisors first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Minot DeBlois Advisors's Bristol-Myers Squibb position peaked at $18.2K in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Minot DeBlois Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.